Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial

Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a new Locations section with New York as a site; removed the New York Locations label and the HHS Vulnerability Disclosure link in this revision.
    Difference
    0.2%
    Check dated 2025-12-23T10:15:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.2, and Revision: v3.2.0 has been removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:15:38.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed a broad notice about potential data delays due to a lapse in government funding, including references to cc.nih.gov and opm.gov for status updates. This notice framed site operations rather than the trial details themselves.
    Difference
    0.4%
    Check dated 2025-11-17T18:36:12.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:10:51.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Update includes a funding-related operations notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    4%
    Check dated 2025-10-13T04:29:29.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:58:10.000Z thumbnail image

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.